Amexdrug Corporation
AXRX
$0.002
$0.000.00%
OTC PK
| 06/30/2013 | 03/31/2013 | ||||
|---|---|---|---|---|---|
| Revenue | -8.78% | -4.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.78% | -4.97% | |||
| Cost of Revenue | -2.46% | -21.06% | |||
| Gross Profit | -31.21% | 244.65% | |||
| SG&A Expenses | -4.61% | 7.56% | |||
| Depreciation & Amortization | 0.00% | 46.28% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.69% | -18.22% | |||
| Operating Income | -58.47% | 394.41% | |||
| Income Before Tax | -61.98% | 339.10% | |||
| Income Tax Expenses | -52.12% | 1,906.98% | |||
| Earnings from Continuing Operations | -66.40% | 271.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -66.40% | 271.96% | |||
| EBIT | -58.47% | 394.41% | |||
| EBITDA | -54.70% | 464.90% | |||
| EPS Basic | -70.00% | 266.67% | |||
| Normalized Basic EPS | -66.67% | 325.00% | |||
| EPS Diluted | -70.00% | 266.67% | |||
| Normalized Diluted EPS | -66.67% | 325.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||